Storia in 17 fonti

Experimental pill offers breakthrough hope in pancreatic cancer fight

An experimental drug for advanced pancreatic cancer significantly extended survival in a major clinical trial, offering fresh hope for improved treatment...

Raccontata da

sciencedaily.com+5 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

dailysabah.comStai leggendo3 mesi fa

Experimental pill offers breakthrough hope in pancreatic cancer fight

Daraxonrasib, a daily oral KRAS inhibitor by Revolution Medicines, nearly doubled median survival in metastatic pancreatic cancer (13.2 vs 6.7 months) in a 500-patient Phase 3 trial, with the FDA fast-tracking review. The drug breaks a decades-long stalemate on KRAS — mutated in 90%+ of pancreatic cases — signaling that the "undruggable" oncology target class is now open, with downstream implications for RAS-driven cancers beyond pancreatic.

originale

Experimental pill offers breakthrough hope in pancreatic cancer fight

Confronto fonti

Experimental pill offers breakthrough hope in pancreatic cancer fight

Timeline cronologica

Pancreatic cancer is deadly and difficult to treat. A new pill could change that

‘Unprecedented’ Revolution data point to paradigm shift in pancreatic cancer

Experimental pill promises new hope for deadly pancreatic cancer

Experimental pill promises new hope for deadly pancreatic cancer | CNN

Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. 'I actually…

Why this new pill for a deadly cancer has doctors excited

This drug can double survival time for pancreatic cancer patients

After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses

Daily pill almost doubles survival time for pancreatic cancer patients in new trial

Daily pill can double survival time for world’s deadliest cancer, trial shows

New drug gives extra months of life to pancreatic cancer patients

Experimental pill promises new hope for deadly pancreatic cancer

Pancreatic cancer breakthrough as pill almost doubles survival time for patients

New drug nearly doubles survival rates in some pancreatic cancer patients, study says

Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. 'I actually started crying' | Fortune

Experimental pill promises new hope for deadly pancreatic cancer | CNN

Experimental pill offers breakthrough hope in pancreatic cancer fight

Why this new pill for a deadly cancer has doctors excited

Experimental drug shows promise against deadly pancreatic cancer

Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival

Landmark cancer trial shows success against ‘undruggable’ cancer — raising hopes for future treatments

Breakthrough Pill Nearly Doubles Survival Time For One of The Deadliest Cancers

Revolution Medicines' Pancreatic Cancer Pill Doubles Survival, Cuts Death Risk 60% in Trial As Stock Sits

This drug can double survival time for pancreatic cancer patients

Experimental pancreatic cancer drug offers new hope in major trial